Bu liste, son piyasa olaylarına dayalı bir analizdir. Yatırım tavsiyesi değildir.
Hakkında
Communications
Specialty Telecommunications
Information
Telecommunications Resellers
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.